1
Radiological prognosticators of HCC Hepatobiliary Pancreat Dis Int，Vol 11，No 6 • December 15，2012 • www.hbpdint.com • Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003;38:200-207. 25 Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403. 26 Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008;85:1726-1732 27 Chan KM, Chou HS, Wu TJ, Lee CF, Yu MC, Lee WC. Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome. Asian J Surg 2011;34:128-134. 28 Bhattacharjya S, Bhattacharjya T, Quaglia A, Dhillon AP, Burroughs AK, Patch DW, et al. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators. Dig Surg 2004;21:152-160. Received January 27, 2012 Accepted after revision June 1, 2012 Joint Liver Cancer Center established by Cleveland Clinic and the First Affiliated Hospital, Zhejiang University in Hangzhou, China A joint liver cancer center has been launched by signing a cooperative agreement between Cleveland Clinic at Cleveland, Ohio, USA and the First Affiliated Hospital, Zhejiang University on November 16, 2012 at Hangzhou, China. In recent years, a series of cooperative projects have been carried out between medical centers of other countries and the First Affiliated Hospital. This endeavor facilitates international cooperation between the First Affiliated Hospital and other oversea centers in faculty training and basic research in liver cancer. (doi: 10.1016/S1499-3872(12)60233-1) News
